The association of heart rate variability with Parkinsonian motor symptom duration

Yonsei Medical Journal

Volumn 55, Issue 5, 2014, Pages 1297-1302

  Harnod, Dorji ^a   Wen, Shu Hui ^b   Chen, Shin Yuan ^b   Harnod, Tomor ^b  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

Author keywords

Autonomic; Heart rate variability; Parkinson's disease

Indexed keywords

LEVODOPA;

ADULT; AGED; ARTICLE; BEHAVIOR; BODY MOVEMENT; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; ELECTROCARDIOGRAPHY; FEMALE; FOURIER TRANSFORMATION; HEART RATE; HEART RATE VARIABILITY; HUMAN; MALE; MIDDLE AGED; MINI MENTAL STATE EXAMINATION; MOTOR DYSFUNCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARASYMPATHETIC FUNCTION; PARKINSONISM; SCORING SYSTEM; SYMPATHETIC FUNCTION; TREMOR; UNIFIED PARKINSON DISEASE RATING SCALE; AUTONOMIC NERVOUS SYSTEM; COMPLICATION; PARKINSON DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; REGRESSION ANALYSIS;

ADULT; AGED; AUTONOMIC NERVOUS SYSTEM; CROSS-SECTIONAL STUDIES; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; REGRESSION ANALYSIS;

EID: 84904765159     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2014.55.5.1297     Document Type: Article

References (22)

1. Jost WH. Autonomic dysfunctions in idiopathic Parkinson's disease. J Neurol 2003;250 Suppl 1:I28-30.
2. Oka H, Mochio S, Onouchi K, Morita M, Yoshioka M, Inoue K. Cardiovascular dysautonomia in de novo Parkinson's disease. J Neurol Sci 2006;241:59-65.
3. Lucetti C, Gambaccini G, Del Dotto P, Ceravolo R, Logi C, Rossi G, et al. Long-term clinical evaluation in patients with Parkinson's disease and early autonomic involvement. Parkinsonism Relat Disord 2006;12:279-83.
4. Vanderlei LC, Pastre CM, Hoshi RA, Carvalho TD, Godoy MF. Basic notions of heart rate variability and its clinical applicability. Rev Bras Cir Cardiovasc 2009;24:205-17.
5. Stein PK, Bosner MS, Kleiger RE, Conger BM. Heart rate variability: a measure of cardiac autonomic tone. Am Heart J 1994; 127:1376-81.
6. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J 1996;17:354-81.
7. Harnod T, Yang CC, Hsin YL, Shieh KR, Wang PJ, Kuo TB. Heart rate variability in children with refractory generalized epilepsy. Seizure 2008;17:297-301.
8. Langston JW, Widner H, Goetz CG, Brooks D, Fahn S, Freeman T, et al. Core assessment program for intracerebral transplantations (CAPIT). Mov Disord 1992;7:2-13.
9. Takase B, Kurita A, Noritake M, Uehata A, Maruyama T, Nagayoshi H, et al. Heart rate variability in patients with diabetes mellitus, ischemic heart disease, and congestive heart failure. J Electrocardiol 1992;25:79-88.
10. Kuo TB, Lin T, Yang CC, Li CL, Chen CF, Chou P. Effect of aging on gender differences in neural control of heart rate. Am J Physiol 1999;277(6 Pt 2):H2233-9.
11. Benarroch EE, Schmeichel AM, Parisi JE. Involvement of the ventrolateral medulla in parkinsonism with autonomic failure. Neurology 2000;54:963-8.
12. Papapetropoulos S, Mash DC. Insular pathology in Parkinson's disease patients with orthostatic hypotension. Parkinsonism Relat Disord 2007;13:308-11.
13. Wakabayashi K, Takahashi H. Neuropathology of autonomic nervous system in Parkinson's disease. Eur Neurol 1997;38 Suppl 2:2-7.
14. Isaias IU, Marotta G, Pezzoli G, Sabri O, Schwarz J, Crenna P, et al. Enhanced catecholamine transporter binding in the locus coeruleus of patients with early Parkinson disease. BMC Neurol 2011;11:88.
15. Ludwig J, Remien P, Guballa C, Binder A, Binder S, Schattschneider J, et al. Effects of subthalamic nucleus stimulation and levodopa on the autonomic nervous system in Parkinson's disease. J Neurol Neurosurg Psychiatry 2007;78:742-5.
16. Bouhaddi M, Vuillier F, Fortrat JO, Cappelle S, Henriet MT, Rumbach L, et al. Impaired cardiovascular autonomic control in newly and long-term-treated patients with Parkinson's disease: involvement of L-dopa therapy. Auton Neurosci 2004;116:30-8.
17. Löhle M, Reichmann H. Controversies in neurology: why monoamine oxidase B inhibitors could be a good choice for the initial treatment of Parkinson's disease. BMC Neurol 2011;11:112.
18. Byrne EA, Fleg JL, Vaitkevicius PV, Wright J, Porges SW. Role of aerobic capacity and body mass index in the age-associated decline in heart rate variability. J Appl Physiol (1985) 1996;81:743-50.
19. Jankovic J, Kapadia AS. Functional decline in Parkinson disease. Arch Neurol 2001;58:1611-5.
20. Kallio M, Suominen K, Bianchi AM, Mäkikallio T, Haapaniemi T, Astafiev S, et al. Comparison of heart rate variability analysis methods in patients with Parkinson's disease. Med Biol Eng Comput 2002;40:408-14.
21. Lucreziotti S, Gavazzi A, Scelsi L, Inserra C, Klersy C, Campana C, et al. Five-minute recording of heart rate variability in severe chronic heart failure: correlates with right ventricular function and prognostic implications. Am Heart J 2000;139:1088-95.
22. Nakagawa M, Iwao T, Ishida S, Yonemochi H, Fujino T, Saikawa T, et al. Circadian rhythm of the signal averaged electrocardiogram and its relation to heart rate variability in healthy subjects. Heart 1998;79:493-6.